What We Do
From 2017 to 2019, HP+ Ghana worked in collaboration with key stakeholders to strengthen the country’s national HIV response. We provided evidence-based recommendations to reduce discrimination at the health facility level and generated cost estimates to help policymakers assess the implications of scaling up HIV treatment through adoption of new HIV treatment protocols.
HP+ used a three-phase “total facility” approach to reduce HIV-related stigma and discrimination in health facilities, including stigma toward key populations. Built on global best practices and adapted to the Ghanaian context, this evidence-based approach yielded significant reductions in drivers and manifestations of stigma among health facility staff, including stigmatizing attitudes toward clients living with HIV and increased willingness to care for key populations. Success was measured through a quantitative survey of health facility staff and clients, focusing on pre- and post-intervention trends among staff and using client data to triangulate and support staff data. Integrating stigma and discrimination-reduction interventions into the health system has the potential to significantly increase access to services and improve quality of care.
HP+ also conducted a strategic costing and policy analysis of Ghana’s antiretroviral therapy program to estimate the costs associated with scaling up treatment. Findings from the study provided critical evidence to support advocacy for increased financing across the clinical cascade. Resource allocation decisions based on this evidence, along with the adoption of differentiated care and treatment protocols, will provide Ghana with an opportunity to effectively achieve ambitious scale-up targets for HIV testing, treatment, and retention.